Arcutis Biotherapeutics Statistics
NASDAQ: ARQTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
26.36-0.81 (-2.98%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Arcutis Biotherapeutics by the numbers
Arcutis Biotherapeutics has a market capitalization of $3.33 billion based on 126.46M shares outstanding. Its trailing P/E ratio is 119.8, and its forward P/E is 24.1. The stock trades 5.4% below its 50-day average and 3.7% above its 200-day average.
Average daily trading volume is 2.58M shares, or about $68.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARQT valuation vs. peer median
| Metric | ARQT | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.33B | $3.37B | -1% |
| Avg. volume | 2.58M | 1.83M | +41% |
Peer median across 8 companies: AMLX, VRDN, IRON, ELVN, PBLS, ABCL, VKTX, XERS.
Valuation
- Market cap
- $3.33B
- P/E (TTM)
- 119.82
- Forward P/E
- 24.09
- Price / sales (latest FY)
- 8.86
- EPS (TTM)
- $0.22
- Shares outstanding
- 126.46M
Price and trading
- Previous close
- 27.17
- Open
- 26.89
- Day range
- 26.29 – 27.46
- 52-week range
- 19.30 – 34.80
- 52-week change
- -10.61%
- Beta
- —
- Volume
- 1.29M
- Average volume
- 2.58M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 3.33B
- Pe
- 119.82
- Forward Pe
- 24.09
- Eps
- 0.22
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 34.80
- Week52 Low
- 19.30
- Avg Volume
- 2.58M
- Shares Outstanding
- 126.46M
- Ma50
- 27.86
- Ma200
- 25.41
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -24.25%
- Pct From52w Low
- 36.62%